Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes

Retrovirology

Volumn 7, Issue , 2010, Pages

  Sloan, Richard D ^a   Donahue, Daniel A ^a,b   Kuhl, Björn D ^a,b   Bar Magen, Tamara ^a   Wainberg, Mark A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; NEF PROTEIN; RALTEGRAVIR; VIRUS DNA; 2 PYRROLIDONE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; CXCR4 PROTEIN, HUMAN; GREEN FLUORESCENT PROTEIN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CD4+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; SIGNAL TRANSDUCTION; SUPERINFECTION; VIRUS DNA CELL DNA INTERACTION; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION; HUMAN; METABOLISM; REPORTER GENE; T LYMPHOCYTE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTI-HIV AGENTS; ANTIGENS, CD4; CELL LINE; DOWN-REGULATION; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PYRROLIDINONES; RECEPTORS, CCR5; RECEPTORS, CXCR4; T-LYMPHOCYTES; VIRUS INTEGRATION;

EID: 77952017246     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-44     Document Type: Article

References (58)

1. Chun T, Carruth L, Finzi D, Shen X, DiGiuseppe J, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387:183-188. 10.1038/387183a0, 9144289.
2. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters H, Chen I. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 1990, 343:85-89. 10.1038/343085a0, 2296295.
3. Sharkey M, Teo I, Greenough T, Sharova N, Luzuriaga K, Sullivan J, Bucy R, Kostrikis L, Haase A, Veryard C, Davaro RE, Cheeseman SH, Daly JS, Bova C, Ellison RT, Mady B, Lai KK, Moyle G, Nelson M, Gazzard B, Shaunak S, Stevenson M. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med 2000, 6:76-81. 10.1038/71569, 10613828.
4. Teo I, Veryard C, Barnes H, An S, Jones M, Lantos P, Luthert P, Shaunak S. Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol 1997, 71:2928-2933. 191420, 9060651.
5. Bukrinsky M, Stanwick T, Dempsey M, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991, 254:423-427. 10.1126/science.1925601, 1925601.
6. Farnet C, Haseltine W. Circularization of human immunodeficiency virus type 1 DNA in vitro. J Virol 1991, 65:6942-6952. 250802, 1834863.
7. Khiytani D, Dimmock N. Characterization of a human immunodeficiency virus type 1 pre-integration complex in which the majority of the cDNA is resistant to DNase I digestion. J Gen Virol 2002, 83:2523-2532.
8. Poon B, Chang M, Chen I. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA. J Virol 2007, 81:10515-10523. 10.1128/JVI.00947-07, 2045493, 17652391.
9. Englund G, Theodore T, Freed E, Engelman A, Martin M. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J Virol 1995, 69:3216-3219. 189028, 7707554.
10. Wiskerchen M, Muesing M. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J Virol 1995, 69:376-386. 188585, 7983732.
11. Wu Y, Marsh J. Early transcription from nonintegrated DNA in human immunodeficiency virus infection. J Virol 2003, 77:10376-10382. 10.1128/JVI.77.19.10376-10382.2003, 228496, 12970422.
12. Kelly J, Beddall M, Yu D, Iyer S, Marsh J, Wu Y. Human macrophages support persistent transcription from unintegrated HIV-1 DNA. Virology 2008, 372:300-312. 10.1016/j.virol.2007.11.007, 2276161, 18054979.
13. Wu Y, Marsh J. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 2001, 293:1503-1506. 10.1126/science.1061548, 11520990.
14. Gillim-Ross L, Cara A, Klotman M. Nef expressed from human immunodeficiency virus type 1 extrachromosomal DNA downregulates CD4 on primary CD4+ T lymphocytes: implications for integrase inhibitors. J Gen Virol 2005, 86:765-771. 10.1099/vir.0.80570-0, 15722538.
15. Ansari-Lari M, Donehower L, Gibbs R. Analysis of human immunodeficiency virus type 1 integrase mutants. Virology 1995, 211:332-335. 10.1006/viro.1995.1412, 7544046.
16. Stevenson M, Haggerty S, Lamonica C, Meier C, Welch S, Wasiak A. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol 1990, 64:2421-2425. 249408, 2157898.
17. Engelman A, Englund G, Orenstein J, Martin M, Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 1995, 69:2729-2736. 188965, 7535863.
18. Wu Y, Beddall M, Marsh J. Rev-dependent lentiviral expression vector. Retrovirology 2007, 4:12. 10.1186/1742-4690-4-12, 1797186, 17286866.
19. Wu Y, Beddall M, Marsh J. Rev-dependent indicator T cell line. Curr HIV Res 2007, 5:394-402. 10.2174/157016207781024018, 2366165, 17627502.
20. Iyer S, Yu D, Biancotto A, Margolis L, Wu Y. Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates. J Virol 2009, 83:8662-8673. 10.1128/JVI.00874-09, 2738211, 19553325.
21. Brussel A, Sonigo P. Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species. J Virol 2004, 78:11263-11271. 10.1128/JVI.78.20.11263-11271.2004, 521838, 15452245.
22. Poon B, Chen I. Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA. J Virol 2003, 77:3962-3972. 10.1128/JVI.77.7.3962-3972.2003, 150668, 12634356.
23. Butler S, Johnson E, Bushman F. Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol 2002, 76:3739-3747. 10.1128/JVI.76.8.3739-3747.2002, 136088, 11907213.
24. Pierson T, Kieffer T, Ruff C, Buck C, Gange S, Siliciano R. Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol 2002, 76:4138-4144. 10.1128/JVI.76.8.4138-4144.2002, 136068, 11907256.
25. Vargas JJ, Gusella G, Najfeld V, Klotman M, Cara A. Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum Gene Ther 2004, 15:361-372. 10.1089/104303404322959515, 15053861.
26. Lu R, Nakajima N, Hofmann W, Benkirane M, Jeang K, Sodroski J, Engelman A, Teh-Jeang K. Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages. J Virol 2004, 78:658-668. 10.1128/JVI.78.2.658-668.2004, 368853, 14694097.
27. Mannioui A, Schiffer C, Felix N, Nelson E, Brussel A, Sonigo P, Gluckman J, Canque B. Cell cycle regulation of human immunodeficiency virus type 1 integration in T cells: antagonistic effects of nuclear envelope breakdown and chromatin condensation. Virology 2004, 329:77-88. 10.1016/j.virol.2004.08.022, 15476876.
28. Bushman F. Measuring covert HIV replication during HAART: the abundance of 2-LTR circles is not a reliable marker. AIDS 2003, 17:749-750. 10.1097/00002030-200303280-00014, 12646799.
29. Gillim-Ross L, Cara A, Klotman M. HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages. Viral Immunol 2005, 18:190-196. 10.1089/vim.2005.18.190, 15802963.
30. Wu Y. The second chance story of HIV-1 DNA: Unintegrated? Not a problem!. Retrovirology 2008, 5:61. 10.1186/1742-4690-5-61, 2483994, 18613958.
31. Cara A, Klotman M. Retroviral E-DNA: persistence and gene expression in nondividing immune cells. J Leukoc Biol 2006, 80:1013-1017. 10.1189/jlb.0306151, 16923918.
32. Hazuda D, Felock P, Witmer M, Wolfe A, Stillmock K, Grobler J, Espeseth A, Gabryelski L, Schleif W, Blau C, Miller M. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 2000, 287:646-650. 10.1126/science.287.5453.646, 10649997.
33. Butler S, Hansen M, Bushman F. A quantitative assay for HIV DNA integration in vivo. Nat Med 2001, 7:631-634. 10.1038/87979, 11329067.
34. Venzke S, Michel N, Allespach I, Fackler O, Keppler O. Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection. J Virol 2006, 80:11141-11152. 10.1128/JVI.01556-06, 1642143, 16928758.
35. Wildum S, Schindler M, Münch J, Kirchhoff F. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J Virol 2006, 80:8047-8059. 10.1128/JVI.00252-06, 1563805, 16873261.
36. Michel N, Allespach I, Venzke S, Fackler O, Keppler O. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol 2005, 15:714-723. 10.1016/j.cub.2005.02.058, 15854903.
37. Pauza C, Galindo J, Richman D. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells. J Exp Med 1990, 172:1035-1042. 10.1084/jem.172.4.1035, 2188596, 2212939.
38. Robinson H, Zinkus D. Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events. J Virol 1990, 64:4836-4841. 247972, 2398529.
39. Wu Y, Yoder A. Chemokine coreceptor signaling in HIV-1 infection and pathogenesis. PLoS Pathog 2009, 5:e1000520. 10.1371/journal.ppat.1000520, 2790611, 20041213.
40. Lama J. The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr HIV Res 2003, 1:167-184. 10.2174/1570162033485276, 15043201.
41. Johnston S, Lobritz M, Nguyen S, Lassen K, Delair S, Posta F, Bryson Y, Arts E, Chou T, Lee B. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. J Virol 2009, 83:11016-11026. 10.1128/JVI.01242-09, 2772777, 19692480.
42. Lassen K, Lobritz M, Bailey J, Johnston S, Nguyen S, Lee B, Chou T, Siliciano R, Markowitz M, Arts E. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog 2009, 5:e1000377. 10.1371/journal.ppat.1000377, 2661022, 19360131.
43. Pugach P, Ray N, Klasse P, Ketas T, Michael E, Doms R, Lee B, Moore J. Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities. Virology 2009, 387:296-302. 10.1016/j.virol.2009.02.044, 2674391, 19303620.
44. Pierson T, Zhou Y, Kieffer T, Ruff C, Buck C, Siliciano R. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J Virol 2002, 76:8518-8531. 10.1128/JVI.76.17.8518-8513.2002, 136977, 12163571.
45. Petitjean G, Al Tabaa Y, Tuaillon E, Mettling C, Baillat V, Reynes J, Segondy M, Vendrell J. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients. Retrovirology 2007, 4:60. 10.1186/1742-4690-4-60, 2048509, 17727722.
46. Levin A, Rosenbluh J, Hayouka Z, Friedler A, Loyter A. Integration of HIV-1 DNA is regulated by interplay between viral rev and cellular LEDGF/p75 proteins. Mol Med 16:34-44. 2765407, 19855849.
47. Levin A, Hayouka Z, Friedler A, Brack-Werner R, Volsky D, Loyter A. A novel role for the viral Rev protein in promoting resistance to Super-infection by Human Immunodeficiency Virus type 1. J Gen Virol 2010,
48. Gelderblom H, Vatakis D, Burke S, Lawrie S, Bristol G, Levy D. Viral complementation allows HIV-1 replication without integration. Retrovirology 2008, 5:60. 10.1186/1742-4690-5-60, 2474848, 18613957.
49. Quan Y, Liang C, Brenner B, Wainberg M. Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants. J Infect Dis 2009, 200:1479-1483. 10.1086/606117, 19758098.
50. Khan M, Brandimarti R, Patel J, Huynh N, Wang J, Huang Z, Fatatis A, Meucci O. Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis. AIDS Res Hum Retroviruses 2004, 20:1063-1071. 10.1089/aid.2004.20.1063, 2669736, 15585097.
51. Cocchi F, DeVico A, Garzino-Demo A, Arya S, Gallo R, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:1811-1815. 10.1126/science.270.5243.1811, 8525373.
52. Davis C, Dikic I, Unutmaz D, Hill C, Arthos J, Siani M, Thompson D, Schlessinger J, Littman D. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997, 186:1793-1798. 10.1084/jem.186.10.1793, 2199136, 9362541.
53. Zaitseva M, Peden K, Golding H. HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors. Biochim Biophys Acta 2003, 1614:51-61. 10.1016/S0005-2736(03)00162-7, 12873765.
54. Tremblay M, Meloche S, Gratton S, Wainberg M, Sékaly R. Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J 1994, 13:774-783. 394876, 8112293.
55. Collins K, Chen B, Kalams S, Walker B, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998, 391:397-401. 10.1038/34929, 9450757.
56. Sastry L, Xu Y, Cooper R, Pollok K, Cornetta K. Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment. Hum Gene Ther 2004, 15:221-226. 10.1089/104303404772680029, 14975194.
57. Yu J, Wu T, Liszewski M, Dai J, Swiggard W, Baytop C, Frank I, Levine B, Yang W, Theodosopoulos T, O'Doherty U. A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients. Virology 2008, 379:78-86. 10.1016/j.virol.2008.05.030, 2610678, 18649912.
58. Donahue D, Sloan R, Kuhl B, Bar-Magen T, Schader S, Wainberg M. Stage-Dependent Inhibition of HIV-1 Replication by Antiretroviral Drugs in Cell Culture. Antimicrob Agents Chemother 2009, 54:1047-1054. 10.1128/AAC.01537-09, 20038621.